Literature DB >> 15138646

[Tissue microarrays. Value of immunohistochemical proliferation markers for serial investigations of head and neck cancer].

S Peters1, M Hambek, W Gstöttner, R Knecht.   

Abstract

BACKGROUND: Tissue microarrays (TMAs) are still seldom used in oncological research, especially that involving otorhinolaryngology, although the benefit of this method has often been reported.
METHODS: We prepared ten different tumor probes from patients with head and neck cancer for immunohistochemistry and performed ki67 and proliferating cell nuclear antigen (PCNA) staining on the usual paraffin sections as well as on TMAs consisting of the same tissue. RESULTS AND
CONCLUSIONS: We conclude that investigation by means of TMA makes oncological research, and especially the screening of tumor probes, much more efficient since a high correlation ( r>0.7, P<0.0001) between both methods was found.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138646     DOI: 10.1007/s00106-003-0914-y

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  13 in total

1.  Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins.

Authors:  M Schoenberg Fejzo; D J Slamon
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 2.  Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.

Authors:  L Bubendorf; A Nocito; H Moch; G Sauter
Journal:  J Pathol       Date:  2001-09       Impact factor: 7.996

3.  Tissue microarrays (TMAs) for high-throughput molecular pathology research.

Authors:  A Nocito; J Kononen; O P Kallioniemi; G Sauter
Journal:  Int J Cancer       Date:  2001-10-01       Impact factor: 7.396

4.  Multitumor "sausage" blocks in immunohistochemistry. Simplified method of preparation, practical uses, and roles in quality assurance.

Authors:  R T Miller; C L Groothuis
Journal:  Am J Clin Pathol       Date:  1991-08       Impact factor: 2.493

5.  [Retrospective analysis of selected tumor markers (p53, PCNA, Ki67; DNA ploidy) and ultrastructure in patients with larynx carcinomas].

Authors:  W Golusiñski; Z Szmeja; J Olofsson; W Biczysko; A Krygier-Stojałzowska; P Majewski
Journal:  HNO       Date:  1998-03       Impact factor: 1.284

Review 6.  Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations.

Authors:  A Hoos; C Cordon-Cardo
Journal:  Lab Invest       Date:  2001-10       Impact factor: 5.662

7.  Tissue microarrays for rapid linking of molecular changes to clinical endpoints.

Authors:  J Torhorst; C Bucher; J Kononen; P Haas; M Zuber; O R Köchli; F Mross; H Dieterich; H Moch; M Mihatsch; O P Kallioniemi; G Sauter
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

8.  Tissue microarrays for gene amplification surveys in many different tumor types.

Authors:  P Schraml; J Kononen; L Bubendorf; H Moch; H Bissig; A Nocito; M J Mihatsch; O P Kallioniemi; G Sauter
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

9.  The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing.

Authors:  H Battifora
Journal:  Lab Invest       Date:  1986-08       Impact factor: 5.662

10.  Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Authors:  J Kononen; L Bubendorf; A Kallioniemi; M Bärlund; P Schraml; S Leighton; J Torhorst; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

View more
  2 in total

1.  Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67.

Authors:  Wafaey Gomaa; Youqiang Ke; Hiroshi Fujii; Timothy Helliwell
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

2.  Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx.

Authors:  Grazia Salerno; Dolores Di Vizio; Stefania Staibano; Giampiero Mottola; Giuseppe Quaremba; Massimo Mascolo; Vieri Galli; Gaetano De Rosa; Luigi Insabato
Journal:  BMC Cancer       Date:  2006-06-01       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.